Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 1 7Phase 3 5Phase 1/2 5Phase EARLY_PHASE1 4Phase NA 2Phase 2/3 2

Status

Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4

Conditions

Breast Neoplasms 182Neoplasms 115Prostatic Neoplasms 103Multiple Myeloma 85Glioblastoma 82Pancreatic Neoplasms 75Glioma 65Brain Neoplasms 60Lung Neoplasms 58Head and Neck Neoplasms 57Melanoma 54Colorectal Neoplasms 54Carcinoma, Non-Small-Cell Lung 53Leukemia, Myeloid, Acute 51Carcinoma, Hepatocellular 50Squamous Cell Carcinoma of Head and Neck 46Recurrence 46Ovarian Neoplasms 45Lymphoma 39Lymphoma, Non-Hodgkin 37Lymphoma, B-Cell 36Sarcoma 35Stomach Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Neoplasm Metastasis 33Solid Tumor 31Hematologic Neoplasms 31Carcinoma, Renal Cell 30Polycystic Ovary Syndrome 27Burkitt Lymphoma 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Sarcoma, Alveolar Soft Part × Clear all
NCT06789081 2026-03-23

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)

AHS Cancer Control Alberta

Phase EARLY_PHASE1 Active not recruiting
1 enrolled
Sarcoma

Sarcoma, Alveolar Soft Part

NCT07104682 2025-08-05

CLIC-YYC-GPNMB

University of Calgary

Phase EARLY_PHASE1 Not yet recruiting
1 enrolled
Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

NCT06827886 2025-07-23

GCAR1

AHS Cancer Control Alberta

Phase EARLY_PHASE1 Completed
1 enrolled
Sarcoma

Sarcoma, Alveolar Soft Part

NCT06813417 2025-04-10

SPS-Q2

University of Calgary

Phase EARLY_PHASE1 Active not recruiting
1 enrolled
Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡